Key Findings
Indian scientists have identified specific gene mutations that cause oral cancer in women from southern India, marking a significant breakthrough in cancer research. The discovery of the CASP8 driver gene mutation presents new possibilities for personalized treatment approaches.
Research Background
India faces one of the world’s highest oral cancer burdens, with particularly alarming rates among women in certain regions. This is largely attributed to the widespread habit of chewing tobacco-infused betel quid, gutka, and related products. While oral cancer has been extensively studied in men, the disease in women has received less attention until now.
A collaborative team from Jawaharlal Nehru Centre for Advanced Scientific Research and BRIC-National Institute of Biomedical Genomics, working with clinicians from Sri Devraj Urs Academy of Higher Education and Research, conducted this groundbreaking female-focused study.
Study Methodology and Findings
Published in the Clinical and Translational Medicine Journal, the research employed advanced sequencing techniques to analyze genetic mutations in female oral cancer patients. The study revealed:
- Ten key genes with significant mutations in the female oral cancer cohort
- CASP8 identified as the primary cancer-causing driver mutation
- TP53 also found to be highly mutated alongside CASP8
- Distinct genetic patterns compared to male oral cancer patients
The combination of TP53 and CASP8 mutations appears to create a particularly aggressive and lethal form of oral cancer that requires further investigation.
AI Analysis and Treatment Implications
Using artificial intelligence and deep learning, researchers digitally analyzed tumor tissues and identified two distinct patient groups with different immune responses. This crucial insight suggests that treatment effectiveness may vary based on individual tumor profiles, paving the way for more targeted therapies.
The research team is now focused on understanding the molecular mechanisms driven by the CASP8 mutation in their next research phase.
